Heparin Market by Product Type (Unfractionated Heparin, Low Molecular Weight Heparin and Ultra-low Molecular Weight Heparin), by Source (Bovine and Porcine) and by Formulation into Oral and Parental: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023
The report covers forecast and analysis for the heparin market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2023 based revenue (USD Billion). The study includes drivers and restraints for the heparin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the heparin market on a global level.
In order to give the users of this report a comprehensive view on the heparin market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, type of form segment and type of formulation segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view on the heparin market by segmenting the market based on product type, source type, type of formulation and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on product type the market is segmented into unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin. On the basis of source type, the market is segmented into bovine and porcine. Based on the type of formulation the market is segmented into oral and parental. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, U.K., Germany, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for heparin market based on individual product type, source, and type of formulation in all the regions and countries.
The report also includes detailed profiles of end players such as Dr. Reddys Laboratories Ltd, Teva Pharmaceutical Industries Ltd., Fresenius SE Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International, Inc., Syntex S.A., and Others.
This report segments the global heparin market as follows:
Global Heparin Market: Product Type Segment Analysis
In order to give the users of this report a comprehensive view on the heparin market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, type of form segment and type of formulation segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view on the heparin market by segmenting the market based on product type, source type, type of formulation and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2023. Based on product type the market is segmented into unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin. On the basis of source type, the market is segmented into bovine and porcine. Based on the type of formulation the market is segmented into oral and parental. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, U.K., Germany, France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for heparin market based on individual product type, source, and type of formulation in all the regions and countries.
The report also includes detailed profiles of end players such as Dr. Reddys Laboratories Ltd, Teva Pharmaceutical Industries Ltd., Fresenius SE Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International, Inc., Syntex S.A., and Others.
This report segments the global heparin market as follows:
Global Heparin Market: Product Type Segment Analysis
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Ultra-low Molecular Weight Heparin (ULMWH)
- Bovine
- Porcine
- Oral
- Parental
- North America
- The U.S.
- Europe
- The UK
- France
- Germany
- The Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- The Middle East and Africa
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
CHAPTER 1. INTRODUCTION
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Global heparin market, 2017 - 2023 (USD Billion)
2.2. Global heparin market: snapshot
CHAPTER 3. HEPARIN MARKET- MARKET DYNAMICS
3.1. Introduction
3.2. Market Drivers
3.2.1. Global heparin market drivers: impact analysis
3.2.2. Increasing treatment of venous thromboembolism
3.3. Market Restraints
3.3.1. Global heparin market restraints: impact analysis
3.3.2. Significant side effects of the porcine heparin are likely to limit the market growth
3.4. Opportunities
3.4.1. Increasing unmet medical needs in developing countries
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. The threat of new entrants
3.5.4. The threat of new substitutes
3.5.5. Degree of competition
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis, by product type segment
3.6.2. Market attractiveness analysis, by source type segment
3.6.3. Market attractiveness analysis, by type of formulation segment
3.6.4. Market attractiveness analysis, by regional segment
CHAPTER 4. GLOBAL HEPARIN MARKET- COMPETITIVE LANDSCAPE
4.1. Company market share analysis
4.1.1. Global heparin market: company market share, 2017
4.2. Strategic development
4.2.1. Acquisitions mergers
4.2.2. New therapy launch
4.2.3. Agreements, partnerships, collaborations and joint ventures
4.2.4. Research and development and regional expansion
4.3. Price trend analysis
CHAPTER 5. GLOBAL HEPARIN MARKET- PRODUCT TYPE SEGMENT ANALYSIS
5.1. Global heparin market: product overview
5.1.1. Global heparin market revenue share, by product type, 2017 and 2023
5.2. Unfractionated Heparin (UFH)
5.2.1. Global heparin market for unfractionated heparin market, 2017 - 2023 (USD Billion)
5.3. Low Molecular Weight Heparin (LMWH)
5.3.1. Global heparin market for low molecular weight heparin market, 2017 - 2023 (USD Billion)
5.4. Ultra-low Molecular Weight Heparin (ULMWH)
5.4.1. Global heparin market for ultra-low molecular weight heparin market, 2017 - 2023 (USD Billion)
CHAPTER 6. GLOBAL HEPARIN MARKET- SOURCE TYPE SEGMENT ANALYSIS
6.1. Global heparin market: form type overview
6.1.1. Global heparin market revenue share, by source type, 2017 and 2023
6.2. Bovine
6.2.1. Global heparin market for bovine, 2017 - 2023 (USD Billion)
6.3. Porcine
6.3.1. Global heparin market for porcine, 2017 - 2023 (USD Billion)
CHAPTER 7. GLOBAL HEPARIN MARKET- TYPE OF FORMULATION SEGMENT ANALYSIS
7.1. Global heparin market: type of formulation overview
7.1.1. Global heparin market revenue share, by type of formulation, 2017 and 2023
7.2. Oral
7.2.1. Global heparin market for oral, 2017 - 2023 (USD Billion)
7.3. Parental
7.3.1. Global heparin market for parental 2017 - 2023 (USD Billion)
CHAPTER 8. GLOBAL HEPARIN MARKET- REGIONAL SEGMENT ANALYSIS
8.1. Global heparin market: regional overview
8.1.1. Global heparin market revenue share, by region, 2017 and 2023
8.2. North America
8.2.1. North America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.2. North America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.3. North America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.2.4. U.S.
8.2.4.1. U.S. heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.4.2. U.S. heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.4.3. U.S. heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.2.5. Canada
8.2.5.1. Canada heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.5.2. Canada heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.5.3. Canada heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.2.6. Rest of North America
8.2.6.1. Rest of North America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.6.2. Rest of North America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.6.3. Rest of North America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3. Europe
8.3.1. Europe heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.2. Europe heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.3. Europe heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.4. U.K.
8.3.4.1. U.K. heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.4.2. U.K. heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.4.3. U.K. heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.5. Germany
8.3.5.1. Germany heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.5.2. Germany heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.5.3. Germany heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.6. France
8.3.6.1. France heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.6.2. France heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.6.3. France heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.7. Italy
8.3.7.1. Italy heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.7.2. Italy heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.7.3. Italy heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.8. Spain
8.3.8.1. Spain heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.8.2. Spain heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.8.3. Spain heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.9. Russia
8.3.9.1. Russia heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.9.2. Russia heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.9.3. Russia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.10.2. Rest of Europe heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.10.3. Rest of Europe heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.2. Asia Pacific heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.3. Asia Pacific heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.4. China
8.4.4.1. China heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.4.2. China heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.4.3. China heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.5. Japan
8.4.5.1. Japan heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.5.2. Japan heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.5.3. Japan heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.6. India
8.4.6.1. India heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.6.2. India heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.6.3. India heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.7. Australia
8.4.7.1. Australia heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.7.2. Australia heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.7.3. Australia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.8. Rest of Asia Pacific
8.4.8.1. Rest of Asia Pacific heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.8.2. Rest of Asia Pacific heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.8.3. Rest of Asia Pacific heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5. Latin America
8.5.1. Latin America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.2. Latin America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.3. Latin America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.4. Brazil
8.5.4.1. Brazil heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.4.2. Brazil heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.4.3. Brazil heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.5. Mexico
8.5.5.1. Mexico heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.5.2. Mexico heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.5.3. Mexico heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.6. Argentina
8.5.6.1. Argentina heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.6.2. Argentina heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.6.3. Argentina heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.7. Rest of Latin America
8.5.7.1. Rest of Latin America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.7.2. Rest of Latin America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.7.3. Rest of Latin America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.2. Middle East and Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.3. Middle East and Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.4. Saudi Arabia
8.6.4.1. Saudi Arabia heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.4.2. Saudi Arabia heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.4.3. Saudi Arabia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.5. UAE
8.6.5.1. UAE heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.5.2. UAE heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.5.3. UAE heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.6. Qatar
8.6.6.1. Qatar heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.6.2. Qatar heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.6.3. Qatar heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.7. South Africa
8.6.7.1. South Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.7.2. South Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.7.3. South Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.8. Rest of Middle East and Africa
8.6.8.1. Rest of Middle East and Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.8.2. Rest of Middle East and Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.8.3. Rest of Middle East and Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
CHAPTER 9. COMPANY PROFILE
9.1. Dr. Reddys Laboratories Ltd.
9.1.1. Overview
9.1.2. Financials
9.1.3. Therapy portfolio
9.1.4. Business strategy
9.1.5. Recent developments
9.2. Teva Pharmaceutical Industries Ltd.
9.2.1. Overview
9.2.2. Financials
9.2.3. Therapy portfolio
9.2.4. Business strategy
9.2.5. Recent developments
9.3. Fresenius SE Co. KGaA
9.3.1. Overview
9.3.2. Financials
9.3.3. Therapy portfolio
9.3.4. Business strategy
9.3.5. Recent developments
9.4. Sanofi
9.4.1. Overview
9.4.2. Financials
9.4.3. Therapy portfolio
9.4.4. Business strategy
9.4.5. Recent developments
9.5. Pfizer, Inc.
9.5.1. Overview
9.5.2. Financials
9.5.3. Therapy portfolio
9.5.4. Business strategy
9.5.5. Recent developments
9.6. LEO Pharma A/S
9.6.1. Overview
9.6.2. Financials
9.6.3. Therapy portfolio
9.6.4. Business strategy
9.6.5. Recent developments
9.7. Aspen
9.7.1. Overview
9.7.2. Financials
9.7.3. Therapy portfolio
9.7.4. Business strategy
9.7.5. Recent developments
9.8. Baxter International, Inc.
9.8.1. Overview
9.8.2. Financials
9.8.3. Therapy portfolio
9.8.4. Business strategy
9.8.5. Recent developments
9.9. Syntex S.A.
9.9.1. Overview
9.9.2. Financials
9.9.3. Therapy portfolio
9.9.4. Business strategy
9.9.5. Recent developments
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Global heparin market, 2017 - 2023 (USD Billion)
2.2. Global heparin market: snapshot
CHAPTER 3. HEPARIN MARKET- MARKET DYNAMICS
3.1. Introduction
3.2. Market Drivers
3.2.1. Global heparin market drivers: impact analysis
3.2.2. Increasing treatment of venous thromboembolism
3.3. Market Restraints
3.3.1. Global heparin market restraints: impact analysis
3.3.2. Significant side effects of the porcine heparin are likely to limit the market growth
3.4. Opportunities
3.4.1. Increasing unmet medical needs in developing countries
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. The threat of new entrants
3.5.4. The threat of new substitutes
3.5.5. Degree of competition
3.6. Market Attractiveness Analysis
3.6.1. Market attractiveness analysis, by product type segment
3.6.2. Market attractiveness analysis, by source type segment
3.6.3. Market attractiveness analysis, by type of formulation segment
3.6.4. Market attractiveness analysis, by regional segment
CHAPTER 4. GLOBAL HEPARIN MARKET- COMPETITIVE LANDSCAPE
4.1. Company market share analysis
4.1.1. Global heparin market: company market share, 2017
4.2. Strategic development
4.2.1. Acquisitions mergers
4.2.2. New therapy launch
4.2.3. Agreements, partnerships, collaborations and joint ventures
4.2.4. Research and development and regional expansion
4.3. Price trend analysis
CHAPTER 5. GLOBAL HEPARIN MARKET- PRODUCT TYPE SEGMENT ANALYSIS
5.1. Global heparin market: product overview
5.1.1. Global heparin market revenue share, by product type, 2017 and 2023
5.2. Unfractionated Heparin (UFH)
5.2.1. Global heparin market for unfractionated heparin market, 2017 - 2023 (USD Billion)
5.3. Low Molecular Weight Heparin (LMWH)
5.3.1. Global heparin market for low molecular weight heparin market, 2017 - 2023 (USD Billion)
5.4. Ultra-low Molecular Weight Heparin (ULMWH)
5.4.1. Global heparin market for ultra-low molecular weight heparin market, 2017 - 2023 (USD Billion)
CHAPTER 6. GLOBAL HEPARIN MARKET- SOURCE TYPE SEGMENT ANALYSIS
6.1. Global heparin market: form type overview
6.1.1. Global heparin market revenue share, by source type, 2017 and 2023
6.2. Bovine
6.2.1. Global heparin market for bovine, 2017 - 2023 (USD Billion)
6.3. Porcine
6.3.1. Global heparin market for porcine, 2017 - 2023 (USD Billion)
CHAPTER 7. GLOBAL HEPARIN MARKET- TYPE OF FORMULATION SEGMENT ANALYSIS
7.1. Global heparin market: type of formulation overview
7.1.1. Global heparin market revenue share, by type of formulation, 2017 and 2023
7.2. Oral
7.2.1. Global heparin market for oral, 2017 - 2023 (USD Billion)
7.3. Parental
7.3.1. Global heparin market for parental 2017 - 2023 (USD Billion)
CHAPTER 8. GLOBAL HEPARIN MARKET- REGIONAL SEGMENT ANALYSIS
8.1. Global heparin market: regional overview
8.1.1. Global heparin market revenue share, by region, 2017 and 2023
8.2. North America
8.2.1. North America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.2. North America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.3. North America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.2.4. U.S.
8.2.4.1. U.S. heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.4.2. U.S. heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.4.3. U.S. heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.2.5. Canada
8.2.5.1. Canada heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.5.2. Canada heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.5.3. Canada heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.2.6. Rest of North America
8.2.6.1. Rest of North America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.2.6.2. Rest of North America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.2.6.3. Rest of North America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3. Europe
8.3.1. Europe heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.2. Europe heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.3. Europe heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.4. U.K.
8.3.4.1. U.K. heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.4.2. U.K. heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.4.3. U.K. heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.5. Germany
8.3.5.1. Germany heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.5.2. Germany heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.5.3. Germany heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.6. France
8.3.6.1. France heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.6.2. France heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.6.3. France heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.7. Italy
8.3.7.1. Italy heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.7.2. Italy heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.7.3. Italy heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.8. Spain
8.3.8.1. Spain heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.8.2. Spain heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.8.3. Spain heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.9. Russia
8.3.9.1. Russia heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.9.2. Russia heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.9.3. Russia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.3.10.2. Rest of Europe heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.3.10.3. Rest of Europe heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.2. Asia Pacific heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.3. Asia Pacific heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.4. China
8.4.4.1. China heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.4.2. China heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.4.3. China heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.5. Japan
8.4.5.1. Japan heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.5.2. Japan heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.5.3. Japan heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.6. India
8.4.6.1. India heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.6.2. India heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.6.3. India heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.7. Australia
8.4.7.1. Australia heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.7.2. Australia heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.7.3. Australia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.4.8. Rest of Asia Pacific
8.4.8.1. Rest of Asia Pacific heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.4.8.2. Rest of Asia Pacific heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.4.8.3. Rest of Asia Pacific heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5. Latin America
8.5.1. Latin America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.2. Latin America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.3. Latin America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.4. Brazil
8.5.4.1. Brazil heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.4.2. Brazil heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.4.3. Brazil heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.5. Mexico
8.5.5.1. Mexico heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.5.2. Mexico heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.5.3. Mexico heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.6. Argentina
8.5.6.1. Argentina heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.6.2. Argentina heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.6.3. Argentina heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.5.7. Rest of Latin America
8.5.7.1. Rest of Latin America heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.5.7.2. Rest of Latin America heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.5.7.3. Rest of Latin America heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6. Middle East and Africa
8.6.1. Middle East and Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.2. Middle East and Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.3. Middle East and Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.4. Saudi Arabia
8.6.4.1. Saudi Arabia heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.4.2. Saudi Arabia heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.4.3. Saudi Arabia heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.5. UAE
8.6.5.1. UAE heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.5.2. UAE heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.5.3. UAE heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.6. Qatar
8.6.6.1. Qatar heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.6.2. Qatar heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.6.3. Qatar heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.7. South Africa
8.6.7.1. South Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.7.2. South Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.7.3. South Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
8.6.8. Rest of Middle East and Africa
8.6.8.1. Rest of Middle East and Africa heparin market revenue, by product type, 2017 - 2023 (USD Billion)
8.6.8.2. Rest of Middle East and Africa heparin market revenue, by source type, 2017 - 2023 (USD Billion)
8.6.8.3. Rest of Middle East and Africa heparin market revenue, by type of formulation, 2017 - 2023 (USD Billion)
CHAPTER 9. COMPANY PROFILE
9.1. Dr. Reddys Laboratories Ltd.
9.1.1. Overview
9.1.2. Financials
9.1.3. Therapy portfolio
9.1.4. Business strategy
9.1.5. Recent developments
9.2. Teva Pharmaceutical Industries Ltd.
9.2.1. Overview
9.2.2. Financials
9.2.3. Therapy portfolio
9.2.4. Business strategy
9.2.5. Recent developments
9.3. Fresenius SE Co. KGaA
9.3.1. Overview
9.3.2. Financials
9.3.3. Therapy portfolio
9.3.4. Business strategy
9.3.5. Recent developments
9.4. Sanofi
9.4.1. Overview
9.4.2. Financials
9.4.3. Therapy portfolio
9.4.4. Business strategy
9.4.5. Recent developments
9.5. Pfizer, Inc.
9.5.1. Overview
9.5.2. Financials
9.5.3. Therapy portfolio
9.5.4. Business strategy
9.5.5. Recent developments
9.6. LEO Pharma A/S
9.6.1. Overview
9.6.2. Financials
9.6.3. Therapy portfolio
9.6.4. Business strategy
9.6.5. Recent developments
9.7. Aspen
9.7.1. Overview
9.7.2. Financials
9.7.3. Therapy portfolio
9.7.4. Business strategy
9.7.5. Recent developments
9.8. Baxter International, Inc.
9.8.1. Overview
9.8.2. Financials
9.8.3. Therapy portfolio
9.8.4. Business strategy
9.8.5. Recent developments
9.9. Syntex S.A.
9.9.1. Overview
9.9.2. Financials
9.9.3. Therapy portfolio
9.9.4. Business strategy
9.9.5. Recent developments
